The primary mechanism of GLP-1 receptor agonists involves binding to GLP-1 receptors on pancreatic beta cells, stimulating glucose-dependent insulin secretion
The value is precisely calculable: six months of net revenues from the drug in question, minus the cost of the pediatric trial program, which typically runs $20 million to $100 million depending on therapeutic area and patient population
Hope is what you have when you dont have data
When paired with insulin or sulfonylureas, hypoglycemia risk rises, so prescribers often lower those doses
PCOS causes symptoms such as irregular menstrual cycles, insulin resistance, hirsutism (excess hair growth, especially on the face think those pesky chin hairs!), acne, male pattern baldness, and anovulation